
Keiretsu Forum
Description
Keiretsu Forum is a distinguished global angel investor network, established in 2000 and headquartered in Orinda, California. It operates on a unique model, bringing together accredited investors to provide capital for early-stage, high-growth companies. With an expansive reach, the forum boasts over 50 chapters spanning four continents, facilitating a collaborative environment where individual angel investors can pool resources and expertise. This structure enables the syndication of deals, allowing for larger investment rounds than a single angel might typically undertake.
The network's investment focus is broad, encompassing diverse sectors such as technology, life sciences, consumer products, and real estate. Keiretsu Forum is particularly recognized for its rigorous, investor-led due diligence process. This meticulous vetting ensures that potential investments are thoroughly scrutinized, providing a layer of confidence for its members and contributing to the success of its portfolio companies. Their commitment extends beyond just capital, often providing strategic guidance and access to a vast network of industry professionals.
Since its inception, Keiretsu Forum has demonstrated a significant impact on the startup ecosystem, having facilitated over $1 billion in funding for more than 1,000 companies globally. While the exact investment amount can vary based on the specific needs of a venture and the collective interest of its members, the typical first cheque size for companies joining their portfolio ranges from $250,000 to $2,000,000. This substantial range underscores their capacity to provide meaningful seed and early-stage capital, supporting promising ventures from various industries in their critical growth phases.
Investor Profile
Keiretsu Forum has backed more than 326 startups, with 3 new investments in the last 12 months alone. The firm has led 34 rounds, about 10% of its total and boasts 44 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Seed, Series A rounds (top funding stages).
- Majority of deals are located in United States, India, Turkey.
- Strong thematic focus on Health Care, Software, Biotechnology.
- Led 3 rounds in the past year.
- Typical check size: $250K – $2M.
Stage Focus
- Series Unknown (45%)
- Seed (25%)
- Series A (14%)
- Angel (6%)
- Series B (3%)
- Convertible Note (3%)
- Pre Seed (2%)
- Series C (1%)
- Post Ipo Equity (1%)
Country Focus
- United States (67%)
- India (14%)
- Turkey (6%)
- Canada (5%)
- Spain (2%)
- United Kingdom (2%)
- France (1%)
- Ireland (1%)
- Israel (1%)
Industry Focus
- Health Care
- Software
- Biotechnology
- Medical
- Manufacturing
- E-commerce
- Medical Device
- Information Technology
- Saas
- Internet
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.